4.7 Article

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Infectious Diseases

The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community

Yihienew M. Bezabih et al.

Summary: There has been a significant increase in the intestinal carriage rate of ESBL E. coli in the community globally over the past 20 years, with the highest rates observed in South-East Asia and the lowest in Europe. Prevention of its spread may require new therapeutic and public health strategies.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Review Microbiology

Past and Present Perspectives on β-Lactamases

Karen Bush

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Review Infectious Diseases

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype

Edward R. Bevan et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Infectious Diseases

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014

Sibylle H. Lob et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)

Article Immunology

The Continuing Plague of Extended-spectrum β-lactamase-producing Enterobacteriaceae Infections

Amos Adler et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)